Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
78.23
-2.61 (-3.23%)
At close: Feb 21, 2025, 4:00 PM
80.00
+1.77 (2.26%)
After-hours: Feb 21, 2025, 5:57 PM EST
Lantheus Holdings Employees
Lantheus Holdings had 834 employees as of December 31, 2023. The number of employees increased by 136 or 19.48% compared to the previous year.
Employees
834
Change (1Y)
136
Growth (1Y)
19.48%
Revenue / Employee
$1,794,723
Profits / Employee
$512,724
Market Cap
5.44B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 834 | 136 | 19.48% |
Dec 31, 2022 | 698 | 86 | 14.05% |
Dec 31, 2021 | 612 | 17 | 2.86% |
Dec 31, 2020 | 595 | 87 | 17.13% |
Dec 31, 2019 | 508 | 20 | 4.10% |
Dec 31, 2018 | 488 | 5 | 1.04% |
Dec 31, 2017 | 483 | 18 | 3.87% |
Dec 31, 2016 | 465 | -9 | -1.90% |
Dec 31, 2015 | 474 | -50 | -9.54% |
Dec 31, 2014 | 524 | 5 | 0.96% |
Dec 31, 2013 | 519 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
LNTH News
- 23 days ago - Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D. - GlobeNewsWire
- 25 days ago - Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PRNewsWire
- 5 weeks ago - Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market - GlobeNewsWire
- 7 weeks ago - Lantheus Holdings: Powerhouse Potential In 2025 - Seeking Alpha
- 2 months ago - Lantheus Holdings: A Growing Business With Dominant Market Share - Seeking Alpha
- 3 months ago - Lantheus Announces Share Repurchase Program - GlobeNewsWire
- 3 months ago - Lantheus to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Lantheus Continues to Commend CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY's Blockbuster Status for 2025 - GlobeNewsWire